Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003057
Filing Date
2021-11-04
Accepted
2021-11-04 16:08:35
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20210930.htm   iXBRL 10-Q 3316929
2 EX-31.1 vir-ex31_1.htm EX-31.1 21355
3 EX-31.2 vir-ex31_2.htm EX-31.2 21291
4 EX-32.1 vir-ex32_1.htm EX-32.1 13154
  Complete submission text file 0000950170-21-003057.txt   11321893

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20210930_pre.xml EX-101.PRE 460184
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20210930_lab.xml EX-101.LAB 640320
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20210930_def.xml EX-101.DEF 338892
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20210930.xsd EX-101.SCH 90078
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20210930_cal.xml EX-101.CAL 55454
10 EXTRACTED XBRL INSTANCE DOCUMENT vir-20210930_htm.xml XML 1950828
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 211379970
SIC: 2836 Biological Products, (No Diagnostic Substances)